Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

R&D BIO ENERGY : revenue, balance sheet and financial ratios

R&D BIO ENERGY is a French company founded 7 years ago, specialized in the sector Production de combustibles gazeux. Based in ANDREZEL (77390), this company of category PME shows in 2022 a revenue of 1.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - R&D BIO ENERGY (SIREN 843220567)
Indicator 2024 2023 2022 2021
Revenue N/C N/C 1 799 565 € N/C
Net income 132 419 € 165 583 € 122 456 € 44 103 €
EBITDA N/C N/C 657 438 € N/C
Net margin N/C N/C 6.8% N/C

Revenue and income statement

In 2024, R&D BIO ENERGY generates positive net income of 132 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 44 k€ -> 132 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

132 419 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 343%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

343.078%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

18.302%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

77.7%

Solvency indicators evolution
R&D BIO ENERGY

Sector positioning

Debt ratio
343.08 2024
2022
2023
2024
Q1: 0.0
Med: 267.17
Q3: 519.85
Average -12 pts over 3 years

In 2024, the debt ratio of R&D BIO ENERGY (343.08) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
18.3% 2024
2022
2023
2024
Q1: 3.56%
Med: 16.41%
Q3: 29.48%
Good

In 2024, the financial autonomy of R&D BIO ENERGY (18.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
10.57 years 2022
2022
Q1: -7.98 years
Med: 0.0 years
Q3: 8.25 years
Watch

In 2022, the repayment capacity of R&D BIO ENERGY (10.57) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 131.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

131.377

Liquidity indicators evolution
R&D BIO ENERGY

Sector positioning

Liquidity ratio
131.38 2024
2022
2023
2024
Q1: 99.25
Med: 213.04
Q3: 371.32
Average -9 pts over 3 years

In 2024, the liquidity ratio of R&D BIO ENERGY (131.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
12.95x 2022
2022
Q1: -19.92x
Med: 0.0x
Q3: 12.23x
Excellent

In 2022, the interest coverage of R&D BIO ENERGY (12.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
R&D BIO ENERGY

Positioning of R&D BIO ENERGY in its sector

Comparison with sector Production de combustibles gazeux

Valuation estimate

Based on 127 transactions of similar company sales (all years), the value of R&D BIO ENERGY is estimated at 366 760 € (range 77 471€ - 1 335 795€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
127 transactions
77k€ 366k€ 1335k€
366 760 € Range: 77 471€ - 1 335 795€
Section all-time Aggregated at NAF section level

Valuation method used

Net Income Multiple
132 419 € × 2.8x = 366 761 €
Range: 77 472€ - 1 335 796€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 127 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Production de combustibles gazeux)

Compare R&D BIO ENERGY with other companies in the same sector:

Frequently asked questions about R&D BIO ENERGY

What is the revenue of R&D BIO ENERGY ?

The revenue of R&D BIO ENERGY in 2022 is 1.8 M€.

Is R&D BIO ENERGY profitable?

Yes, R&D BIO ENERGY generated a net profit of 132 k€ in 2024.

Where is the headquarters of R&D BIO ENERGY ?

The headquarters of R&D BIO ENERGY is located in ANDREZEL (77390), in the department Seine-et-Marne.

Where to find the tax return of R&D BIO ENERGY ?

The tax return of R&D BIO ENERGY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does R&D BIO ENERGY operate?

R&D BIO ENERGY operates in the sector Production de combustibles gazeux (NAF code 35.21Z). See the 'Sector positioning' section above to compare the company with its competitors.